In the MDA-MB-157 line the percentage of CD44+/CD24− cells did not change significantly upon WT1 loss (Fig. 7B), suggesting that down-regulation of WT1 does not affect the ‘stemness’ of breast cancer cells. Here, CD44 is linked to breast cancer.